Megan Hall

Megan P. Hall, PhD is Vice President of Medical & Corporate Affairs, and a Distinguished Scientist, at GRAIL, where she leads the Medical Affairs team on overall strategy and tactical execution to ensure broad adoption of our multi-cancer early detection test. She is a member of the GRAIL executive leadership team. Prior to establishing the Corporate Affairs function at GRAIL, Dr. Hall established and built GRAIL’s Medical Affairs group, supporting the development and launch of Galleri, a blood-based multi-cancer early detection test. Previously, Megan was Director of Medical Communications at Jazz Pharmaceuticals, where she led healthcare provider-focused engagement and education strategies for the company’s hematology/oncology and chronic pain product portfolios. Before Jazz, Megan established and built a Medical Communication team at Natera to support the launch and evolution of the Panorama non-invasive prenatal test, and was an editor at the flagship open access journal, PLOS Biology. She also held various research roles funded by the American Heart Association, California Institute of Regenerative Medicine, National Institutes of Health, and the Howard Hughes Research Foundation. Megan earned a BS in Biological Sciences from the University of California at Santa Barbara, and a PhD in Microbiology, Immunology, and Molecular Genetics from the University of California at Los Angeles.